Noriko Doki
Tokyo Metropolitan Komagome Hospital
23 Papers
80 Citations
Noriko Doki is an academic researcher from Tokyo Metropolitan Komagome Hospital. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 9, co-authored 23 publications. Previous affiliations of Noriko Doki include University of Tokyo.
Chat about Author
Papers
Secondary solid tumors after allogeneic hematopoietic SCT in Japan
Akira Yokota,S Ozawa,T. Masanori,H Akiyama,Kumi Ohshima,Yoshinobu Kanda,Satoshi Takahashi,Takehiko Mori,Chiaki Nakaseko,Masahiro Onoda,Kishi K,Noriko Doki,Nobuyuki Aotsuka,Heiwa Kanamori,Atsuo Maruta,Hisashi Sakamaki,Shinichiro Okamoto +16 more
TL;DR: The data suggest that the incidence and risk factors of secondary solid tumors in Japanese allo-HSCT recipients are comparable to those reported in Western countries and emphasize that the early detection of solid tumors has a crucial role in improving OS.
63
Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients.
Naoki Shingai,Taku Morito,Yuho Najima,Takeshi Kobayashi,Noriko Doki,Kazuhiko Kakihana,Kazuteru Ohashi,M Ando +7 more
TL;DR: Early AKI may portend a poor survival for allo-SCT recipients, according to a prospective cohort study performed to understand the significance of the onset timing in allogeneic SCT recipients.
38
Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation.
Yoshihiro Inamoto,Tomohiro Matsuda,Ken Tabuchi,Saiko Kurosawa,Hideki Nakasone,Hisakazu Nishimori,Satoshi Yamasaki,Noriko Doki,Koji Iwato,Takehiko Mori,Satoshi Takahashi,Hiromasa Yabe,Akio Kohno,Hirohisa Nakamae,Toru Sakura,Hisako Hashimoto,Junichi Sugita,Hiroatsu Ago,Takahiro Fukuda,Tatsuo Ichinohe,Yoshiko Atsuta,Takuya Yamashita +21 more
TL;DR: Most subsequent solid cancers occurred at younger ages than primary cancers, emphasizing the need for cancer screening at younger age, and thereafter solid cancers showed similar or worse survival compared with primary cancers.
31
Visceral varicella zoster virus infection after allogeneic stem cell transplantation.
Noriko Doki,S. Miyawaki,Masatsugu Tanaka,D. Kudo,Atsushi Wake,Kumi Oshima,H. Fujita,T. Uehara,Rie Hyo,Takehiko Mori,Satoru Takahashi,Shinichiro Okamoto,Hisashi Sakamaki +12 more
TL;DR: Varicella zoster virus (VZV) disease is one of the major infectious complications that can occur after allogeneic hematopoietic stem cell transplantation (allo‐HSCT) and few studies so far have included a large number of patients.
25
An Open-Label, Single-Arm, Multicenter Study of Ibrutinib in Japanese Patients With Steroid-dependent/Refractory Chronic Graft-Versus-Host Disease.
Noriko Doki,Masako Toyosaki,Souichi Shiratori,Tomoo Osumi,Masaya Okada,Toshiro Kawakita,Masashi Sawa,Takayuki Ishikawa,Yasunori Ueda,Nozomi Yoshinari,Susumu Nakahara +10 more
- 01 Oct 2021
TL;DR: Ibrutinib showed clinical benefit with an acceptable safety profile in steroid-dependent/refractory cGVHD patients in a Phase 1b/2 study (PCYC-1129-CA, NCT02195869).
19